Depending on the stimulation context, IL-21 can be pro-apoptotic for B cells [6] [7] [8] or can
promote their differentiation to memory and plasma cells. 7, 9 IL-21 can also potently augment T cell proliferation as a comitogen 10 and cooperates with IL-7 or IL-15 to drive the proliferation of resting CD8 + T cells. 11 It can also augment NK-cell activity [12] [13] [14] [15] [16] and exert actions on dendritic cells 17 and monocytes/macrophages. 18 Furthermore, IL-21 has been reported to have anti-tumor effects in a range of model systems and implicated as contributing to autoimmunity 5 . However, relatively little is known regarding signaling by this important cytokine.
Like other γ c -dependent cytokines, 19 IL-21 activates the Janus family tyrosine kinases, Jak1 and Jak3. 2, 20 Whereas IL-2, IL-7, IL-9, and IL-15 primarily activate Stat5a
and Stat5b, and IL-4 primarily activates Stat6, IL-21 has been reported to activate Stat1, Stat3, and Stat5, with preferential activation of Stat1 and Stat3. 1, 2, [20] [21] [22] For personal use only. on October 28, 2017. by guest www.bloodjournal.org From Phosphorylation of tyrosine residues in the cytoplasmic domain of cytokine receptors can regulate downstream signaling pathways by providing docking sites for SH2 (Src homology 2) and/or PTB (phosphotyrosine binding) domain-containing proteins, 23, 24 including STAT proteins. We now investigate the role of IL-21R tyrosines in mediating IL-21-induced STAT protein activation, and we also demonstrate the importance of these tyrosines as well as the MAPK and PI 3-kinase (PI3K)/Akt pathways in IL-21-mediated proliferation.
Methods

Mice. Mice lacking IL-21R
4 and Stat1 25 have been described. Mice lacking Stat3 in T cells (T-cell Stat3) were generated by breeding Stat3 f/f mice 26 with transgenic mice expressing
Cre recombinase under the control of CD4 regulatory elements. 27 Mice lacking Stat1 and T-cell Stat3 were generated by standard interbreeding. 28 Mice were analyzed at 6-16 wks of age. Experiments were performed under protocols approved by Animal Use and Care
Committees at NIH and the NYU School of Medicine, in accord with NIH guidelines.
In Vitro Cell Culture. Splenocytes were prepared by pressing spleens through fine nylon screens. Erythrocytes were depleted with ACK lysis buffer. 11 Splenic B cells (>90% pure) and CD8 + T cells (>85% pure) were positively selected using paramagnetic Microbeads conjugated to anti-CD45R (B220) and anti-CD8α (Ly-2) mAbs, respectively, per the manufacturer's instructions (Miltenyi Biotec). Cells were cultured in RPMI 1640 medium
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From containing 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 2mM L-glutamine, and 50 µM β-mercaptoethanol (RPMI 1640 complete medium) with human IL-2 (Roche), human IL-15 (PeproTech), or mouse IL-21 (R&D Systems). Human IL-2 and IL-15 were used as these efficiently stimulate mouse as well as human cells. IL-2 is quantified by Roche in U/ml whereas IL-15 and Il-21 are quantified by PeproTech and R&D Systems, respectively, by mass; these units were therefore used in this study. To inhibit PI3K or MAPK, cells were pre-treated with DMSO (as a control), 50 nM wortmannin, or 50 uM PD98059 (both from EMD Biosciences and dissolved in DMSO) at 37°C for 30 min, followed by addition of cytokines. For studying cell division, cells were labeled with 5 µM CFSE or 10 µM DDAO-SE (Molecular Probes) for 15 min at 37°C. Cells were counted and analyzed on a BD FACSort flow cytometer with CellQuest software (BD Biosciences), and data analyzed with FlowJo software (Tree Star, Inc.).
Vectors and In Vitro Mutagenesis.
A mouse IL-21R cDNA was cloned into pRV-IRES-GFP (provided by Ken Murphy, Washington University). IL-21R mutations were made with QuickChange (Stratagene) using oligonucleotides designed to change Tyr (TAC) to Phe (TTC) codons sequentially at Y510, Y397, Y369, Y361, Y319, and Y281, thus generating IL-21R-F510 (in which only Y510 is mutated to F) and IL-21R-F all (in which all Ys are mutated to Fs) constructs. Oligonucleotides were also designed to mutate back single tyrosines from IL-21R-F all to yield the IL-21R-Y281, -319, -Y361, Y369, -Y397, and -Y510 constructs. Mutants were confirmed by sequencing.
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From Stable transfection of Ba/F3 cells. Ba/F3 cell, an IL-3-dependent cell line, was maintained in RPMI 1640 complete medium containing 5% WEHI-3B conditioned medium (WEHI-CM) as a source of IL-3 or 0.25 ng/ml murine IL-3 (PeproTech).
Transfectants expressing WT and mutant IL-21R were generated by electroporating 2 x 10 6 cells in 200 µl with linearized plasmids (pRV-IRES-GFP) containing IL-21R constructs and pCIneo (Promega), using a Gene Pulser (Bio-Rad; 300 V, 250 µF).
29 After 4 h, cells
were aliquoted into 96-well plates, selected by using 1 mg/ml G418 (GIBCO/BRL), and analyzed for IL-21R expression by flow cytometry with GFP. 1 legend), and no suppression was seen for p-Stat3 or p-Stat5.
IL-21-induced activation of Stat1 and Stat3 is mediated by Y510.
There are six tyrosines in the human and mouse IL-21R cytoplasmic domains ( Fig.   2A ). Mouse IL-21R Y281, Y361, Y369, Y397, and Y510 are conserved in the human;
while the residues surrounding mouse Y319 and human Y317 differ, the relative position of this tyrosine is similar. To investigate the importance of these residues for signaling, we generated a series of IL-21R tyrosine to phenyalanine mutants ( Fig. 2B ), and transfected these or wild-type (WT) IL-21R into IL-3-dependent pro-B Ba/F3 cells, which lack IL-21R but can proliferate in response to IL-21 when IL-21R is expressed. 8, 10 We confirmed similar expression of each mutant by flow cytometry (Fig. 2C ).
Given the induction of Stat1, Stat3, and Stat5 by IL-21 ( Fig. 1 35 For these experiments, we used the Ba/F3 stable transfectants described in Fig 
IL-21R Y510 is critical for maximal IL-21-mediated proliferation.
We next evaluated the role of IL-21R tyrosines for proliferation, initially using the Ba/F3 stable transfectants described above. As compared to the WT IL-21R construct, the IL-21R-F all mutant exhibited greatly diminished thymidine incorporation, with some proliferation evident only at 100 ng/ml IL-21 (Fig. 4A , WT vs. F all ,), suggesting that there is at least some IL-21R tyrosine-independent proliferation that is mediated by high concentrations of IL-21. Constructs with only Y361, Y369, or Y397 were similar to the F all mutant, those with Y281 or Y319 exhibited somewhat more proliferation, but the construct retaining only Y510 mediated a proliferative response similar to WT (Fig. 4A ) and was the only to exhibit significant proliferation at the lowest concentration of IL-21. We also measured cell cycle progression by labeling cells with Far Red DDAO-SE, an aminereactive cell tracer. Consistent with the thymidine incorporation data, the IL-21R-Y510
and WT transfectants had similar IL-21-induced DDAO-SE dilution profiles (Fig. 4B , panels m-o vs. e-g), whereas cells expressing IL-21R-F all divided much less than the WT For personal use only. on October 28, 2017. by guest www.bloodjournal.org From construct even at 100 ng/ml IL-21 (Fig. 3A, panel k vs. g ). As expected, all the transfectants exhibited WT levels of proliferation to IL-3 (panels d, h, l, and p).
Because of possible clonal variation in stable transfectants, we also analyzed Ba/F3 cells transiently transfected by retroviral transduction with the empty vector (pRV) or WT, F all , Y510, or F510 IL-21R constructs (Fig. 4C) . As with the stable transfectants, Y510 mediated similar IL-21-induced proliferation to that of the WT construct, whereas F all had low proliferation (Fig. 4C , panels e-g, i-k, and m-o). Interestingly, Y510-independent effects of IL-21 were indicated by the ability of the IL-21R-F510 mutant to mediate some DDAO dilution (Fig. 4C , panels r and s vs. q), albeit at a decreased level.
We also evaluated the role of these tyrosines in primary B cells by transducing IL-21R-deficient B cells with WT and mutant IL-21R retroviral constructs ( In addition to the Jak-STAT pathway, certain γ c -dependent cytokines can activate MAPK and PI3K/Akt pathways, and for example, in the case of IL-2, these pathways are To further evaluate the possible roles of the MAPK and PI3K pathways in IL-21-mediated proliferation, we used the PI3K inhibitor wortmannin and the MAPK inhibitor PD98059 and examined their effects in Ba/F3 transfectants (Fig. 6C ) using CFSE.
Treatment with wortmannin (Fig. 6C , panels f and g vs. b and c) tended to decrease proliferation but not at a statistically significant level, treatment with PD98059 had a significant effect (panels j and k vs. b and c), and the combination of wortmannin and PD98059 essentially abrogated proliferation (panels n and o vs. b and c). These were specific rather than toxic effects, as these agents had little if any effect on IL-3-mediated (Fig. 6D, panels h, l, and p vs. d) . Thus, the MAPK and PI3K pathways contribute to IL-21-mediated proliferation.
Discussion
We have analyzed the role of tyrosine residues in the IL-21R cytoplasmic domain and found that simultaneous mutation of all 6 tyrosines greatly diminished IL-21-induced proliferation and that Y510 alone can mediate a full proliferative response. IL-21R is most closely related to IL-2Rβ, which transduces IL-2-induced proliferation signals by activating at least three signaling pathways: the Jak-STAT, MAPK, and PI3K pathways. 40 Of the 6 tyrosines in the IL-2Rβ cytoplasmic domain, Y392 and Y510 mediate STAT protein activation, whereas Y338 mediates tyrosine phosphorylation of Shc. 32,33,45 These 3 tyrosines each contribute to a proliferative signal and together mediate a full proliferative response. 32 In the case of IL-21R, the Y510 construct that retains only the C-terminal tyrosine mediates a full proliferative response.
We found that IL- 21 (Fig. 6C ), whereas this treatment had no effect on IL-3-induced proliferation.
These data suggest that full IL-21-mediated proliferation may require cooperative effects of these three pathways, either at transcriptional level by co-regulating certain gene(s) critical for cell cycle progression, or at a functional level by regulating parallel or sequential cascades that lead to cell proliferation. Author's contribution statement: R. Z. designed research, performed research, collected data, analyzed data, and wrote the paper. R. S. performed research, collected data, analyzed data, and wrote the paper. E. C. and W. Z. performed research and collected data.
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